| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 36 |
| 1 | PREDNISONE | 22 |
| 2 | BISOPROLOL FUMARATE | 16 |
| 3 | APIXABAN | 13 |
| 4 | GABAPENTIN | 13 |
| 5 | IBUPFROFEN | 13 |
| 6 | IBUPROFEN | 13 |
| 7 | IBUPROFEN 200 MG | 13 |
| 8 | IBUPROFEN 200MG | 13 |
| 9 | IBUPROFEN CAPSULE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DENOSUMAB-BMWO | 1 | 0.0303 |
| 1 | AVANAFIL | 1 | 0.0143 |
| 2 | LIDOCAINE HCL 3% | 1 | 0.0022 |
| 3 | CHOLESTERINUM | 2 | 0.0018 |
| 4 | PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE | 1 | 0.0012 |
| 5 | TERCONAZOLE | 1 | 0.0012 |
| 6 | AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL | 3 | 0.0012 |
| 7 | MITOTANE | 2 | 0.0011 |
| 8 | MEPERIDINE HYDROCHLORIDE | 9 | 0.0010 |
| 9 | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 47 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 29 |
| 2 | Proton Pump Inhibitor [EPC] | 20 |
| 3 | Opioid Agonist [EPC] | 14 |
| 4 | Factor Xa Inhibitor [EPC] | 13 |
| 5 | Calcium [EPC] | 12 |
| 6 | Integrin Receptor Antagonist [EPC] | 12 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 12 |
| 8 | Benzodiazepine [EPC] | 11 |
| 9 | Estrogen [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Agonist/Antagonist [EPC] | 2 | 0.0008 |
| 1 | Antiparasitic [EPC] | 1 | 0.0002 |
| 2 | Pediculicide [EPC] | 1 | 0.0002 |
| 3 | Thrombopoietin Receptor Agonist [EPC] | 3 | 0.0002 |
| 4 | Bismuth [EPC] | 1 | 0.0002 |
| 5 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Integrin Receptor Antagonist [EPC] | 12 | 0.0001 |
| 7 | Cannabinoid [EPC] | 1 | 0.0001 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 5 | 0.0001 |
| 9 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |